RSS

GlaxoSmithKline (GSK)

Pharmaceutical giant GSK has announced a major acquisition of the biotech company Tesaro to help bolster its oncology pipeline. more

News

EPM speaks to BakerHicks about the challenges in building a state-of-the-art aseptic manufacturing facility. more

Opinion

It has been revealed that GlaxoSmithKline (GSK) — a global science-led healthcare company — has signed up to the Contextual Recruitment System (CRS) run by diversity recruitment specialist, Rare, to gain a more diverse range of talent. more

News

May and Trump

AL hutluht / Shutterstock.com

A black-tie dinner has been arranged for UK business leaders — including big pharma CEOs — and the US president, Donald Trump, to be hosted by the prime minister, Theresa May, according to an article published in the Financial Times (FT). more

News

GlaxoSmithKline (GSK) is set to open the doors of its site in Stevenage this week to host the Medicines Manufacturing Industry Partnership (MMIP) annual conference, taking place on Thursday 7 June. more

News

A strategic agreement has been signed by GlaxoSmithKline (GSK) and Orchard Therapeutics, involving the transfer of GSK’s portfolio of approved and investigational rare disease gene therapies to Orchard. more

News

Healthcare solutions provider, Novartis, has entered into an agreement with GlaxoSmithKline to divest its 36.5% stake in its consumer healthcare joint venture for $13 billion. more

News

A patient and a pharmacy level drug alert recall has been issued by the Medicines and Healthcare products Regulatory Agency (MHRA) for three specific lots of asthma inhalers as they may not deliver the full number doses more

News

Science-led global healthcare company, GlaxoSmithKline (GSK) has welcomed the UK government’s announcement of the Life Sciences Sector Deal, by announcing £40 million investment in genomic research. more

News

Diagnostics company, Owlstone Medical, has announced that GlaxoSmithKline (GSK) will incorporate its Breath Biopsy platform into the clinical development programme of danirixin — a novel GSK pipeline drug candidate for respiratory disease. more

Technology

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

GlaxoSmithKline (GSK) has announced that its once-daily single inhaler triple therapy, Trelegy Ellipta, for the treatment of chronic obstructive pulmonary disease (COPD) has been granted marketing authorisation by the European Commission. more

Technology

The Food and Drug Administration (FDA) has granted breakthrough therapy designation to GlaxoSmithKline (GSK) for its investigational B-cell mutation agent (BCMA) monoclonal antibody-drug conjugate, for relapsed and refractory multiple myeloma more

News

The House of Lords Science and Technology Committee will hear evidence from pharmaceutical companies, including AstraZeneca and GlaxoSmithKline (GSK), this week in its continued inquiry into the life sciences and industrial strategy. more

News

Digital solution provider for respiratory medicine, Propeller Health, is expanding its digital health collaboration with GlaxoSmithKline (GSK) for the improvement of asthma and chronic obstructive pulmonary disease (COPD) management. more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

GlaxoSmithKline (GSK) has made several announcements regarding its forthcoming plans to improve the efficiency and competitiveness of its manufacturing network. more

News

Exscientia and GlaxoSmithKline (GSK) have entered into a strategic collaboration to apply an AI-enabled platform in the discovery of novel and selective small molecules for up to 10 disease-related targets. more

News

Positive results from the SLS in asthma have been announced by GSK and Innoviva, demonstrating that patients initiated on treatment with Relvar Ellipta significantly improved asthma control compared with usual care. more

News

The World Health Organisation Regional Office for Africa (WHO/AFRO) has announced that Ghana, Kenya and Malawi will take part in the malaria vaccine pilot implementation programme starting in 2018. more

News